Maria Rita Emma

1.1k total citations
25 papers, 846 citations indexed

About

Maria Rita Emma is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Maria Rita Emma has authored 25 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Hepatology and 6 papers in Epidemiology. Recurrent topics in Maria Rita Emma's work include Cancer Mechanisms and Therapy (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver physiology and pathology (4 papers). Maria Rita Emma is often cited by papers focused on Cancer Mechanisms and Therapy (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver physiology and pathology (4 papers). Maria Rita Emma collaborates with scholars based in Italy, United States and France. Maria Rita Emma's co-authors include Melchiorre Cervello, Giuseppa Augello, Giuseppe Montalto, Antonina Azzolina, Antonella Cusimano, James A. McCubrey, Roberto Puleio, Lydia Giannitrapani, Guido Ruggero Loria and Maria Luisa Bondı̀ and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Maria Rita Emma

25 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Rita Emma Italy 18 456 152 123 116 104 25 846
Giuseppa Augello Italy 21 529 1.2× 192 1.3× 129 1.0× 165 1.4× 140 1.3× 35 1.0k
Antonella Cusimano Italy 22 738 1.6× 221 1.5× 119 1.0× 232 2.0× 138 1.3× 35 1.2k
Yin‐Kwan Wong China 13 505 1.1× 132 0.9× 113 0.9× 85 0.7× 58 0.6× 28 965
Sha Zeng China 17 653 1.4× 280 1.8× 81 0.7× 285 2.5× 55 0.5× 32 1.2k
Daniel Borja–Cacho United States 12 628 1.4× 91 0.6× 158 1.3× 231 2.0× 34 0.3× 41 1.1k
Hongfei Tong China 18 392 0.9× 141 0.9× 63 0.5× 133 1.1× 71 0.7× 36 867
Xingkai Liu China 15 366 0.8× 97 0.6× 162 1.3× 116 1.0× 27 0.3× 39 692
Wenyi Jin China 19 399 0.9× 113 0.7× 44 0.4× 111 1.0× 71 0.7× 43 842
Junjie Hu China 17 420 0.9× 234 1.5× 140 1.1× 98 0.8× 17 0.2× 56 815

Countries citing papers authored by Maria Rita Emma

Since Specialization
Citations

This map shows the geographic impact of Maria Rita Emma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Rita Emma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Rita Emma more than expected).

Fields of papers citing papers by Maria Rita Emma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Rita Emma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Rita Emma. The network helps show where Maria Rita Emma may publish in the future.

Co-authorship network of co-authors of Maria Rita Emma

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Rita Emma. A scholar is included among the top collaborators of Maria Rita Emma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Rita Emma. Maria Rita Emma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Augello, Giuseppa, Maria Rita Emma, Antonina Azzolina, et al.. (2021). The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma. Cancer Letters. 519. 250–262. 12 indexed citations
2.
Borrello, María Teresa, Maria Rita Emma, Angela Listì, et al.. (2021). NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response. The FASEB Journal. 35(3). e21395–e21395. 12 indexed citations
3.
Emma, Maria Rita, Giuseppa Augello, Antonina Azzolina, et al.. (2020). GSK-3 in liver diseases: Friend or foe?. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(9). 118743–118743. 19 indexed citations
4.
Emma, Maria Rita, Lydia Giannitrapani, Daniela Cabibi, et al.. (2020). Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1865(12). 158792–158792. 29 indexed citations
5.
Augello, Giuseppa, Maria Rita Emma, Antonella Cusimano, et al.. (2020). The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment. Cells. 9(6). 1427–1427. 58 indexed citations
6.
Fröhlich, Jan, Tommaso Mazza, Maria Rita Emma, et al.. (2020). GDF11 induces mild hepatic fibrosis independent of metabolic health. Aging. 12(20). 20024–20046. 17 indexed citations
7.
Cusimano, Antonella, Maurizio Soresi, Giuseppe Montalto, et al.. (2020). Hepatocellular Carcinoma: A Difficult Cancer to Treat. Critical Reviews™ in Oncogenesis. 26(2). 11–25. 2 indexed citations
8.
Soresi, Maurizio, Daniela Cabibi, Rosaria Vincenza Giglio, et al.. (2020). The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods. BioMed Research International. 2020(1). 5023157–5023157. 28 indexed citations
9.
Cervello, Melchiorre, Maria Rita Emma, Giuseppa Augello, et al.. (2020). New landscapes and horizons in hepatocellular carcinoma therapy. Aging. 12(3). 3053–3094. 40 indexed citations
10.
Akula, Shaw M., Stephen L. Abrams, Linda S. Steelman, et al.. (2019). RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma. Expert Opinion on Therapeutic Targets. 23(11). 915–929. 71 indexed citations
11.
Tesauro, Diego, et al.. (2019). Synthetic peptide-labelled micelles for active targeting of cells overexpressing EGF receptors. Amino Acids. 51(8). 1177–1185. 4 indexed citations
12.
Augello, Giuseppa, Caterina Fusilli, Tommaso Mazza, et al.. (2018). Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample. OMICS A Journal of Integrative Biology. 22(4). 274–282. 7 indexed citations
13.
Augello, Giuseppa, Martina Di Modica, Antonina Azzolina, et al.. (2018). Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells. Cell Death and Disease. 9(2). 28–28. 31 indexed citations
14.
Augello, Giuseppa, Maria Rita Emma, Antonina Azzolina, et al.. (2018). Cationic Solid Lipid Nanoparticles as Non Viral Vectors for the Inhibition of Hepatocellular Carcinoma Growth by RNA Interference. Journal of Biomedical Nanotechnology. 14(5). 1009–1016. 22 indexed citations
15.
Cusimano, Antonella, Antonina Azzolina, Giuseppa Augello, et al.. (2017). Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation. International Journal of Oncology. 51(2). 533–544. 77 indexed citations
16.
Cervello, Melchiorre, Giovanna Pitarresi, Barbara Porsio, et al.. (2017). Nanoparticles of a polyaspartamide-based brush copolymer for modified release of sorafenib: In vitro and in vivo evaluation. Journal of Controlled Release. 266. 47–56. 30 indexed citations
17.
Cervello, Melchiorre, Giuseppa Augello, Antonella Cusimano, et al.. (2017). Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma. Advances in Biological Regulation. 65. 59–76. 41 indexed citations
18.
Emma, Maria Rita, Juan Iovanna, Dimcho Bachvarov, et al.. (2016). NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance. Cell Death and Disease. 7(6). e2269–e2269. 92 indexed citations
19.
Augello, Giuseppa, Roberto Puleio, Maria Rita Emma, et al.. (2016). A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells. Cell Cycle. 15(4). 573–583. 32 indexed citations
20.
Bondı̀, Maria Luisa, et al.. (2015). Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells. International Journal of Pharmaceutics. 493(1-2). 75–85. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppa Augello Breakdown of academic impact, for papers by Antonella Cusimano Breakdown of academic impact, for papers by Yin‐Kwan Wong Breakdown of academic impact, for papers by Sha Zeng Breakdown of academic impact, for papers by Daniel Borja–Cacho Breakdown of academic impact, for papers by Hongfei Tong Breakdown of academic impact, for papers by Xingkai Liu Breakdown of academic impact, for papers by Wenyi Jin Breakdown of academic impact, for papers by Junjie Hu
Rankless by CCL
2026